The US stem cell therapy market has shown a tremendous growth over the past few years. The stem cell therapies are now considered one of the most efficient treatments for the chronic diseases like Cancer, CVD and others, and high prevalence of these diseases in the country has propelled the overall market growth. As per our new research on the sector called “US Stem Cell Market Analysis”, the therapeutic banking market is projected to grow at a CAGR of around 21% during 2010-2012.
Our research finds that the increasing awareness among patients about the innovative therapies has boosted the demand of stem cell therapies in the country. The report tries to discover out all the factors that have contributed to the high growth of the therapeutics banking market in the country. The report also includes various key market trends like regenerative medicines, cord blood banking market and others that have grown in line with the development of the stem cell industry. Besides, the key disease segments, in which the role of therapeutics banking has increased significantly, have also been analyzed in the report.
The government has played an important role in the development of stem cell industry in the US. Earlier, the research on embryonic stem cells was banned in the country and this had blocked the growth of stem cell market, but now Obama administration has lifted the ban. This decision will play an important role in deciding the future direction of the stem cell market. In this regard, our report provides complete information on all the government initiatives and funding in the respective areas.
“US Stem Cell Market Analysis” provides an in-depth analysis of the US stem cell market. The report provides valuable information on the key players of the industry along with their business details, which will prove useful to clients while they make their investment decisions.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM191.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today’s globally competitive environment.
